alnylam pharmaceuticals inc
Judy Lieberman M.D., Ph.D.
Member of Scientific Advisory Board, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Judy Lieberman, M.D., Ph.D. is Professor of pediatrics at the Harvard Medical School, Director of the Division of AIDS at Harvard Medical School, and a senior investigator in the Immune Disease Institute. Dr. Lieberman is board certified in internal medicine and hematology, a widely known expert in translational medicine, and a pioneer in the therapeutic use of RNAi, particularly through the development of innovative delivery tools. Dr. Lieberman and her colleagues ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|George W. Hebard III, M.B.A||Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary|
Enzon Pharmaceuticals Inc.
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|